Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder

被引:0
作者
Rast, Jessica E. [1 ]
Anderson, Kristy A. [1 ]
Roux, Anne M. [1 ]
Shattuck, Paul T. [1 ]
机构
[1] Drexel Univ, AJ Drexel Autism Inst, 3020 Market St,Suite 560, Philadelphia, PA 19130 USA
关键词
attention-deficit/hyperactivity disorder; autism; psychotropic medication; PSYCHOTROPIC MEDICATION; SPECTRUM DISORDER; HEALTH-CARE; CHILDREN; ADOLESCENTS; PREVALENCE;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE: Children with autism spectrum disorder (ASD) may benefit from medication to treat a diverse array of behaviors and health conditions common in this population including co-occurring conditions associated with ASD, such as attention-deficit/ hyperactivity disorder (ADHD) and anxiety. However, prescribing guidelines are lacking and research providing national estimates of medication use in youth with ASD is scant. We examined a nationally representative sample of children and youth ages 6 to 17 with a current diagnosis of ASD to estimate the prevalence and correlates of psychotropic medication. METHODS: This study used data from the 2016 and 2017 National Survey of Children's Health. We estimated unadjusted prevalence rates and used multivariable logistic regression to estimate the odds of medication use in children and youth across 3 groups: those with ASD-only, those with ASD and ADHD, and those with ADHD-only. RESULTS: Two thirds of children ages 6 to 11 and three quarters of youth ages 12 to 17 with ASD and ADHD were taking medication, similar to children (73%) and youth with ADHD-only (70%) and more than children (13%) and youth with ASD-only (22%). There were no correlates of medication use that were consistent across group and medication type. Youth with ASD and ADHD were more likely to be taking medication for emotion, concentration, or behavior than youth with ADHD-only, and nearly half took ASD-specific medication. CONCLUSIONS: This study adds to the literature on medication use in children and youth with ASD, presenting recent, nationally representative estimates of high prevalence of psychotropic drug use among children with ASD and ADHD.
引用
收藏
页码:272 / 279
页数:8
相关论文
共 27 条
  • [1] REVISITING THE BEHAVIORAL-MODEL AND ACCESS TO MEDICAL-CARE - DOES IT MATTER
    ANDERSEN, RM
    [J]. JOURNAL OF HEALTH AND SOCIAL BEHAVIOR, 1995, 36 (01) : 1 - 10
  • [2] [Anonymous], 2011, Practice Parameter for the Use of Atypical Antipsychotic Medications in Children and Adolescents
  • [3] Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014
    Baio, Jon
    Wiggins, Lisa
    Christensen, Deborah L.
    Maenner, Matthew J.
    Daniels, Julie
    Warren, Zachary
    Kurzius-Spencer, Margaret
    Zahorodny, Walter
    Rosenberg, Cordelia Robinson
    White, Tiffany
    Durkin, Maureen S.
    Imm, Pamela
    Nikolaou, Loizos
    Yeargin-Allsopp, Marshalyn
    Lee, Li-Ching
    Harrington, Rebecca
    Lopez, Maya
    Fitzgerald, Robert T.
    Hewitt, Amy
    Pettygrove, Sydney
    Constantino, John N.
    Vehorn, Alison
    Shenouda, Josephine
    Hall-Lande, Jennifer
    Braun, Kim Van Naarden
    Dowling, Nicole F.
    [J]. MMWR SURVEILLANCE SUMMARIES, 2018, 67 (06): : 1 - 23
  • [4] An Update on Medication Management of Behavioral Disorders in Autism
    Baribeau, Danielle A.
    Anagnostou, Evdokia
    [J]. CURRENT PSYCHIATRY REPORTS, 2014, 16 (03)
  • [5] Child and Adolescent Health Measurement Initiative (CAHMI), 2019, NAT SURV CHILDR HLTH
  • [6] Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum Disorders
    Coury, Daniel L.
    Anagnostou, Evdokia
    Manning-Courtney, Patricia
    Reynolds, Ann
    Cole, Lynn
    Mccoy, Robin
    Whitaker, Agnes
    Perrin, James M.
    [J]. PEDIATRICS, 2012, 130 : S69 - S76
  • [7] Prevalence and Correlates of Psychotropic Medication Use in Adolescents with an Autism Spectrum Disorder with and without Caregiver-Reported Attention-Deficit/Hyperactivity Disorder
    Frazier, Thomas W.
    Shattuck, Paul T.
    Narendorf, Sarah Carter
    Cooper, Benjamin P.
    Wagner, Mary
    Spitznagel, Edward L.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (06) : 571 - 579
  • [8] The Design and Implementation of the 2016 National Survey of Children's Health
    Ghandour, Reem M.
    Jones, Jessica R.
    Lebrun-Harris, Lydie A.
    Minnaert, Jessica
    Blumberg, Stephen J.
    Fields, Jason
    Bethell, Christina
    Kogan, Michael D.
    [J]. MATERNAL AND CHILD HEALTH JOURNAL, 2018, 22 (08) : 1093 - 1102
  • [9] 'Diagnostic overshadowing': worse physical health care for people with mental illness
    Jones, Simon
    Howard, Louise
    Thornicroft, Graham
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2008, 118 (03) : 169 - 171
  • [10] Jopp DA, 2001, AM J MENT RETARD, V106, P416, DOI 10.1352/0895-8017(2001)106<0416:DORAR>2.0.CO